[go: up one dir, main page]

DK165221C - Belagte transplantater og fremgangsmaade til belaegning af disse - Google Patents

Belagte transplantater og fremgangsmaade til belaegning af disse

Info

Publication number
DK165221C
DK165221C DK119286A DK119286A DK165221C DK 165221 C DK165221 C DK 165221C DK 119286 A DK119286 A DK 119286A DK 119286 A DK119286 A DK 119286A DK 165221 C DK165221 C DK 165221C
Authority
DK
Denmark
Prior art keywords
coating
procedures
transplants
transplant
layer
Prior art date
Application number
DK119286A
Other languages
English (en)
Other versions
DK119286A (da
DK119286D0 (da
DK165221B (da
Inventor
Kent C Cochrum
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of DK119286D0 publication Critical patent/DK119286D0/da
Publication of DK119286A publication Critical patent/DK119286A/da
Publication of DK165221B publication Critical patent/DK165221B/da
Application granted granted Critical
Publication of DK165221C publication Critical patent/DK165221C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Chemically Coating (AREA)
  • Fertilizers (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Prostheses (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Catalysts (AREA)
  • Electroplating Methods And Accessories (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK119286A 1985-03-14 1986-03-14 Belagte transplantater og fremgangsmaade til belaegning af disse DK165221C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71166485A 1985-03-14 1985-03-14
US71166485 1985-03-14

Publications (4)

Publication Number Publication Date
DK119286D0 DK119286D0 (da) 1986-03-14
DK119286A DK119286A (da) 1986-09-15
DK165221B DK165221B (da) 1992-10-26
DK165221C true DK165221C (da) 1993-03-22

Family

ID=24859010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK119286A DK165221C (da) 1985-03-14 1986-03-14 Belagte transplantater og fremgangsmaade til belaegning af disse

Country Status (10)

Country Link
US (1) US4696286A (da)
EP (1) EP0195577B1 (da)
JP (1) JPH07100661B2 (da)
AT (1) ATE75409T1 (da)
CA (1) CA1267851A (da)
DE (1) DE3685046D1 (da)
DK (1) DK165221C (da)
FI (1) FI90628C (da)
IL (1) IL78110A (da)
NO (1) NO166836C (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935000A (en) * 1986-04-03 1990-06-19 East Carolina University Extracellular matrix induction method to produce pancreatic islet tissue
US5128170A (en) * 1989-05-11 1992-07-07 Kanegafunchi Kagaku Kogyo Kabushiki Kaisha Method for manufacturing medical device having a highly biocompatible surface
JPH05501971A (ja) * 1989-09-15 1993-04-15 カイロン・オフサルミクス・インコーポレイテッド 合成レンズの上皮化達成法
IL103284A0 (en) * 1991-10-31 1993-02-21 Transtech Medical Inc Transplant protective coating
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
CA2109065C (en) * 1992-02-24 2004-03-30 Anton-Lewis Usala Bioartificial endocrine device
US5834005A (en) * 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5429821A (en) * 1992-05-29 1995-07-04 The Regents Of The University Of California Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
US5578314A (en) * 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
WO1993024076A1 (en) * 1992-05-29 1993-12-09 The Regents Of The University Of California Coated transplant and method for making same
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
WO1994018906A1 (en) * 1993-02-18 1994-09-01 New England Deaconess Hospital, Corp. Implantable artificial organ
AU695120B2 (en) * 1993-06-07 1998-08-06 Baylor College Of Medicine Use of an MHC class I suppressor drug for the treatment of autoimmune diseases and transplantation rejection
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
EP0759692B1 (en) * 1994-05-20 2009-02-25 Breonics, Inc. Method monitoring viability of transplantable organs
WO1995031944A1 (en) * 1994-05-20 1995-11-30 Vec Tec, Inc. Methods rendering grafts nonthrombogenic and substantially nonimmunogenic
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
CA2214088A1 (en) * 1995-03-03 1996-09-12 Metabolex Inc. Novel encapsulation process by a gelling polymer
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
US6060640A (en) * 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
EP0747046A3 (en) * 1995-05-19 1997-12-03 Baxter International Inc. Permeable immunoisolation membrane structures for implantation of cells in host tissue
DE69637216D1 (de) * 1995-09-27 2007-10-04 Univ Emory Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem
US7041634B2 (en) 1995-09-27 2006-05-09 Emory University Method of inhibiting immune system destruction of transplanted viable cells
US5855613A (en) * 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
DE69637842D1 (de) * 1995-10-26 2009-04-02 Paul P Latta Induktion von immunologischer Toleranz
EP0822857A1 (en) * 1996-02-23 1998-02-11 Circe Biomedical, Inc. Novel artificial pancreas
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
ATE444084T1 (de) * 1998-11-12 2009-10-15 Internat Mfg Group Inc Hämostatische vernetzte dextranperlen verwendbar zur schnellen blutgerinnung und hämostase
WO2000074701A2 (en) * 1999-06-05 2000-12-14 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
EP1224259A4 (en) * 1999-09-27 2005-04-27 Univ Florida INVERSION OF INSULIN DEPENDENT DIABETES BY ISOLATED STEM CELLS, PROGENITOR ISLANDIC CELLS, AND INSULAR TYPE STRUCTURES
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
WO2001070022A1 (en) * 2000-03-21 2001-09-27 Yuichi Mori Coating materials for biological tissues, coated biological tissues and method of coating biological tissues
EP1289537B1 (en) * 2000-05-31 2005-11-30 Encelle, Inc. Method of treating chronic ulcers
US6649384B2 (en) 2000-07-05 2003-11-18 Islet Technology, Inc. System and method for encapsulating biological material by applying electrostatic charge to capsules
KR100380569B1 (ko) * 2000-10-24 2003-04-26 주식회사 메디프렉스 고분자 결합을 이용한 췌장소도 막의 표면개질 방법
US7255983B2 (en) * 2000-11-03 2007-08-14 Vitrolife Ab Evaluation and preservation solution
AU2002361902A1 (en) * 2001-12-31 2003-07-24 Ares Medical, Inc. Hemostatic compositions and methods for controlling bleeding
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
RU2009132949A (ru) * 2007-02-02 2011-03-10 Юниверсити Оф Майами (Us) Терапевтические гибридные имплантируемые устройства
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915369D0 (pt) * 1969-02-27 1973-03-13 Bayer Ag Emprego de inibidores biologicos de proteases para conservacao de orgaos tecidos e alimentos
US3629390A (en) * 1969-12-18 1971-12-21 Us Interior Avian specific bio-affecting preparation and treatment method
IL47062A (en) * 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
US4251387A (en) * 1979-04-17 1981-02-17 Damon Corporation Process for preparing semipermeable microcapsules
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
JPS6059010B2 (ja) * 1979-10-02 1985-12-23 工業技術院長 マイクロカプセル
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4495288A (en) 1981-03-13 1985-01-22 Damon Biotech, Inc. Method of culturing anchorage dependent cells
US4407957A (en) * 1981-03-13 1983-10-04 Damon Corporation Reversible microencapsulation of a core material
US4439521A (en) * 1981-10-21 1984-03-27 Ontario Cancer Institute Method for producing self-reproducing mammalian pancreatic islet-like structures
JPS6018179A (ja) * 1983-07-12 1985-01-30 三浦　喜温 人工肝臓用材料
IL72787A (en) * 1983-09-01 1987-12-31 Damon Biotech Inc Polyionic microencapsulation of viable cells
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
GB8500121D0 (en) * 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells

Also Published As

Publication number Publication date
DK119286A (da) 1986-09-15
US4696286A (en) 1987-09-29
DE3685046D1 (de) 1992-06-04
DK119286D0 (da) 1986-03-14
IL78110A0 (en) 1986-07-31
IL78110A (en) 1991-04-15
FI861083L (fi) 1986-09-15
EP0195577A2 (en) 1986-09-24
NO166836B (no) 1991-06-03
NO860858L (no) 1986-09-15
CA1267851A (en) 1990-04-17
EP0195577A3 (en) 1988-08-03
DK165221B (da) 1992-10-26
FI90628B (fi) 1993-11-30
JPS61222443A (ja) 1986-10-02
FI90628C (fi) 1994-03-10
JPH07100661B2 (ja) 1995-11-01
ATE75409T1 (de) 1992-05-15
FI861083A0 (fi) 1986-03-14
NO166836C (no) 1991-09-11
EP0195577B1 (en) 1992-04-29

Similar Documents

Publication Publication Date Title
DK165221C (da) Belagte transplantater og fremgangsmaade til belaegning af disse
DK552280A (da) Partikler til binding af biologisk aktive substanser praeparat paa basis af disse partikler og fremgangsmaade til fremstilling deraf
DK63581A (da) Sammensat genstand af polytetrafluorethylen og fremgangsmaade til fremstilling af samme
DK323583A (da) Fremgangsmaade til immobilisering af biologiske materialer
DK442783D0 (da) Fremgangsmade til fremstilling af et immobiliseret enzympraeparat
ES8801549A1 (es) Mejoras en la fabricacion de laminas adhesivas desprendibles.
MX9707571A (es) Adhesivos de epoxi con promotores de adhesion de ditiooxamida
DK312685D0 (da) Fremgangsmaade til fordeling af belastningen af et sejl, og sejlkonstruktion med en saaledes fordelt belastning
FR2648985B1 (fr) Element de culture hors-sol
DE59306762D1 (de) Aktivierte Trägermaterialien, ihre Herstellung und Verwendung
DK153388C (da) Fremgangsmaade til fremstilling af spraengstof, saadant til plast bundet spraengstof samt fremgangsmaade til fremstilling af formlegemer af naevnte spraengstof
DK472187D0 (da) Fremgangsmaade og anlaeg til transport af stykformede materialer
NO883827D0 (no) Fremgangsmaate for paafoering av belegg paa flatglass.
DK554486D0 (da) Substrat til kulturplante
ATE46943T1 (de) Gaslager, lagerteil und fuer solch ein gaslager geeigneter lagerwerkstoff.
DK105984A (da) Substrat til fluorbestemmelse af biologiske vaesker
DK597886A (da) Fremgangsmaade til paafoering af tryk paa laedersubstrater
DK669887A (da) Fremgangsmaade til formering af loegplanter
DK319685A (da) Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne
SE8604991D0 (sv) Snake venom growth arresting peptide
NO851647L (no) Adhesjonsmiddel til aa forbinde overflater i ammunisjon som inneholder eksplosive ladninger.
DK0608175T3 (da) Trykfølsom klæbefolie til beskyttelse af materialer og klæbestof, som indgår i dens struktur
DK673688D0 (da) Monoklone antistoffer, hybridom-cellelinier til f remstilling af antistofferne, fremgangsmaade til fremstilling af antistofferne og cellelinierne samt anvendelse af antistofferne
DK554088A (da) Fremgangsmaade til fremstilling af traematerialer
DK360789A (da) Plasmider til fremstilling af alfa-amylase i bacillus

Legal Events

Date Code Title Description
PBP Patent lapsed